Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SuperFade is a range of topical skincare products developed by Plunkett Pharmaceuticals, an Australian company specializing in hyperpigmentation correction. The core medicated products in the line, SuperFade Treatment Cream and SuperFade Face Treatment Cream, are formulated with 2% hydroquinone, which is considered a gold standard for skin lightening. Hydroquinone works by inhibiting the production of melanin within melanocytes, specifically by targeting the enzymatic conversion of tyrosine. This action helps to fade unwanted dark spots, melasma, freckles, and age spots. The brand has been established in the Australian market for over 40 years and is available over-the-counter in pharmacies. The product range also includes non-medicated complementary products like accelerator serums designed to enhance the results of the hydroquinone-based treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SuperFade.